Treatment outcomes of esophageal cancer in Eastern Africa: protocol of a multi-center, prospective, observational, open cohort study

Table 3 Data collected during TOEC-Eastern Africa study

Collected data	Baseline	Prior to treatment	During treatment	Follow up^a
Sociodemographic
Age	x
Sex	x
Ethnicity	x
Occupation	x
Location of permanent residence	x
Highest level of education completed	x
Annual household income	x
Health insurance status	x
Smoking and alcohol use	x
Clinical data
Medical History	x
HIV status (date of and last CD4 count, use of antiretrovirals)	x
Date/method of diagnosis	x
Histopathological data (if applicable)	x
Endoscopic findings (location/length of tumor)	x
Imaging (if applicable)^b	x
Use of opiate medications for pain control	x	x		x
Hospitalizations			x	x
Vital status (including cause of death, if applicable)			x	x
Treatment
Prior EC treatment (if applicable)	x
EC treatment received, including delays/interruptions in treatment and reasons			x
Complications			x
Response assessment (if applicable)			x
Quality of life
Modified Rosenblatt Index^c	x	x		x

EC Esophageal cancer
^aFollow up assessments performed 1 month after initiation of treatment, 3 months after initiation of treatment, and then every 3 months until death or loss to follow up
^bAny imaging modality performed during baseline assessment, including chest x-ray, ultrasound, computed tomography, positron emissions tomography, etc.
^cThe Modified Rosenblatt Index assesses the following: Dysphagia, Odynophagia, ‘Chest and/or Back pain,’ WHO performance status, and ‘Overall Well-being’ since starting treatment

ISSN: 1471-2407